N@N

BARE, BC, MPG, PNM, ARNA, GERN Expected To Be Lower After Earnings Releases on Thursday

^{Published on 2009-10-27 10:00:23, Last Modified on 2010-12-22 17:20:54 - WOPRAI}
 

October 27, 2009 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, October 29th and determining how the stocks have performed after their last 12 quarterly, 6 quarterly and September earnings reports. Bare Escentuals (NASDAQ: BARE), Brunswick Corp (NYSE: BC), Maguire Properties (NYSE: MPG), PNM Resources (NYSE: PNM), Arena Pharmaceuticals (NASDAQ: ARNA) and Geron Corp (NASDAQ: GERN) are all expected to be lower after their earnings are released Thursday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go lower after earnings are released Thursday:

Symbol Company # of Reports Quarter Release Time

BARE Bare Escentuals, Inc. 12 quarters Q3 After

BC Brunswick Corp 12 quarters Q3 Before

MPG Maguire Properties Inc. 12 quarters Q3 After

PNM PNM Resources Inc. 12 quarters Q3 Before

ARNA Arena Pharmaceuticals October earnings Q3 After

GERN Geron Corporation 12 quarters Q3 After

Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event because the information is so vital to the market's perception of the vitality of that company.

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

Bare Escentuals, Inc. (NASDAQ: BARE), together with its subsidiaries, engages in the development, marketing, and sale of cosmetics, and skin care and body care products under bareMinerals, RareMinerals, Buxom, and md formulations brands worldwide. The companya�s cosmetics products include foundation products; various eye, cheek, and face products, such as blushes, all-over-face colors, finishing powders, liner shadows, eyeshadows, and glimmers; and fashionable color cosmetics and accessories, including prep-products, lipsticks, lip glosses, lip liners, and mascaras. Its skin care products include facial cleanser, facial mist, moisturizer, nighttime skin treatment, and acne treatment products. In addition, the company retails cleansers, corrective treatments, antioxidant moisturizers and sun protectors, as well as a line of professional-use-only products for use by aestheticians, such as glycolic peels. It markets its products through premium wholesale customers, company-owned boutiques, spas and salons, home shopping television, infomercials, online shopping, and international distributors. The company was formerly known as STB Beauty, Inc. and changed its name to Bare Escentuals, Inc. in February 2006. Bare Escentuals, Inc. was founded in 1976 and is headquartered in San Francisco, California.

Brunswick Corporation (NYSE: BC) provides recreation products worldwide. The companya�s Boat segment manufactures luxury sportfishing convertibles and motoryachts under Cabo and Hatteras brands; yachts, sport yachts, sport cruisers, and runabouts under Sea Ray brand; sport cruisers and runabouts under Bayliner and Maxum brands; motoryachts under Meridian brand; yachts and sport cruisers under Sealine brand; fiberglass fishing boats under Boston Whaler, Lund, Triton, and Trophy brands; aluminum fishing, utility, pontoon, and deck boats under Crestliner, Harris, Lowe, Lund, Princecraft, and Triton brands; and deck and runabout boats under the Kayot brand. Its Marine Engine segment offers sterndrive propulsion systems, inboard and outboard engines, and water jet propulsion systems under the Mercury, Mercury MerCruiser, Mariner, Mercury Racing, Mercury SportJet, and Mercury Jet Drive brand names, as well as engine parts and marine accessories under the Quicksilver, Mercury Precision Parts, Mercury Propellers, and MotorGuide brand names. Brunswicka�s Fitness segment provides cardiovascular fitness equipment, such as treadmills, total body cross-trainers, stair climbers, and stationary exercise bicycles; and strength-training equipment under the Life Fitness and Hammer Strength brands. Its Bowling and Billiards segment produces bowling products, such as bowling balls and capital equipment; bowling pins and bowling consumer products; and consumer and commercial billiards tables, table games, foosball tables, and related accessories. As of December 31, 2008, it had 104 bowling centers. Brunswick serves primarily the state/local/foreign governments; independent boat builders; private health clubs; fitness facilities operated by professional sports teams; the military; governmental agencies; corporations; hotels; schools; and universities. The company was founded in 1845 and is headquartered in Lake Forest, Illinois.

Maguire Properties, Inc. (NYSE: MPG), a real estate investment trust (REIT), engages in the ownership, management, acquisition, and development of office and real estate properties primarily in California. As of June 30, 2005, the company owned a portfolio of 25 commercial real estate properties, including 22 office and retail projects, a 350-room hotel, 6 off-site parking garages totaling approximately 5,969 spaces, and onsite structured and surface parking totaling approximately 26,549 spaces. It also owned undeveloped land that could support approximately 11.8 million square feet of office, retail, structured parking, and residential uses, as of the above date. The company has elected to be treated as a REIT under the Internal Revenue Code of 1986. As a REIT, it would not be subject to federal income tax, provided it distributes at least 90% of its taxable income to its shareholders. The company was founded in 1965 and is headquartered in Los Angeles, California.

PNM Resources, Inc. (NYSE: PNM), together with its subsidiaries, operates in energy and energy-related businesses. It primarily engages in the generation, transmission, and distribution of electricity in the United States and New Mexico. The company generates electricity using coal, nuclear, natural gas, and wind energy. It also provides regulated transmission and distribution services. PNM Resources, through its 50% interest in Optim Energy, focuses on unregulated electric operations, including the development, operation, and ownership of diverse generation assets and wholesale marketing principally within the areas of Texas. As of December 31, 2008, the company had a generation capacity of approximately 2,713 megawatts. It provides electricity primarily to residential, commercial, and industrial customers. The company was founded in 1917 and is based in Albuquerque, New Mexico.

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing oral drugs in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company also discovers small molecule drug candidates that target G protein-coupled receptors (GPCRs). Its clinical development programs include lorcaserin in Phase 3 trial program for the treatment of obesity; APD791, an anti-thrombotic drug candidate, which has completed Phase 1a and Phase 1b clinical trials; and APD125 that is in Phase 2b clinical trial for the treatment of insomnia. The companya�s clinical development programs also include APD597, an oral GPR119 agonist that is in Phase 1 clinical trial for the treatment of type 2 diabetes; APD916 drug candidate, which has completed preclinical development for the treatment of narcolepsy and cataplexy; and APD811, a preclinical drug candidate for the treatment of pulmonary arterial hypertension. Its drug candidates use GPCR-focused drug discovery and development approach, as well as technologies, including constitutively activated receptor technology and melanophore technology. The company has collaborations with Merck & Co., Inc. to develop therapeutics for atherosclerosis and related disorders; and Ortho-McNeil-Janssen Pharmaceuticals, Inc. to further develop compounds for the potential treatment of type 2 diabetes and other disorders. Arena Pharmaceuticals, Inc. was founded in 1997 and is based in San Diego, California.

Geron Corporation (NASDAQ: GERN), a biopharmaceutical company, develops therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, and diabetes. The company develops a range of anti-cancer therapies, including anti-cancer therapies based on telomerase inhibitors and telomerase therapeutic vaccines, as well as focuses on the development of products using telomerase as a marker for cancer diagnosis, prognosis, patient monitoring, and screening. Its products include GRN163 and GRN163L, which are telomerase inhibitors for the treatment of chronic lymphoproliferative diseases, solid tumors, non-small cell-lung cancer, breast cancer, and multiple myeloma, which are in Phase I trials; and GRNVAC1, a telomerase cancer vaccine that is in Phase II clinical trial for the treatment of acute myelogenous leukemia. Geron Corporation also develops human embryonic stem cell-based therapeutics, with its spinal cord injury treatment. The company has research, development, and commercialization license agreement with Merck & Co., Inc. to use telomerase in non-dendritic cell cancer vaccines; and a license agreement with Sienna Cancer Diagnostics to detect telomerase for in vitro cancer diagnosis. Geron Corporation was founded in 1990 and is based in Menlo Park, California.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641